Elanco Animal Health Incorporated ELAN
Set alert
At close · Oct 30
After hours · Oct 30, 5:05 PM ET
- YTD
- +1.90%
- 1 year
- +2.17%
- Open
- 23.48
- Prev close
- 23.24
- Mkt cap
- 11.52B
- Vol
- 3.45M
- Avg vol
- 6.18M
- EPS
- -0.41
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 22.93
- High
- 23.48
- Forward P/E
- 18.12
- Beta
- 1.71
- Short ratio
- 5.57
- Inst. own
- 115.51%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 6, 2026
- 50-d avg
- 23.13
- 200-d avg
- 23.80
- 1y target
- 30.23
MAX chart
Events in this range
- Aug 7, 2025Earnings: 0.26; estimate 0.2; surprise 30%
- Nov 5, 2025Earnings: 0.19; estimate 0.13; surprise 46.15%
- Feb 24, 2026Earnings: 0.13; estimate 0.11; surprise 18.18%
- May 6, 2026Earnings: 0.4; estimate 0.3456; surprise 15.74%
- Jul 22, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
- Aug 5, 2026Earnings: 0.34; estimate 0.2692; surprise 26.3%
- Aug 6, 2026Rating: Keybanc · Overweight → Overweight
- Aug 6, 2026Rating: UBS · Buy → Buy
- Oct 16, 2026Rating: Goldman Sachs · — → Buy
- Oct 20, 2026Downgrade: Jefferies · Buy → Hold
- Oct 29, 2026Rating: Morgan Stanley · Equal-Weight → Equal-Weight
Signals (162)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 29, 2026 | 2 days ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 16, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| RSI: Overbought | Feb 2, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 8, 2025 | 10 months ago |
| RSI: Overbought | Nov 17, 2025 | 11 months ago |
| RSI: Overbought | Aug 11, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| SMA: Bullish | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | May 5, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Nov 18, 2024 | 1 year ago |
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| SMA: Bearish | Sep 2, 2024 | 2 years ago |
| SMA: Bullish | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 24, 2024 | 2 years ago |
| MACD: Buy Signal | May 20, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bearish | Apr 15, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 1, 2024 | 2 years ago |
| RSI: Overbought | Feb 19, 2024 | 2 years ago |
| RSI: Overbought | Dec 25, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 13, 2023 | 2 years ago |
| SMA: Bullish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Nov 6, 2023 | 2 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 2, 2023 | 3 years ago |
| SMA: Bearish | Sep 18, 2023 | 3 years ago |
| SMA: Bullish | Sep 11, 2023 | 3 years ago |
| SMA: Bearish | Sep 4, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jun 12, 2023 | 3 years ago |
| SMA: Bearish | Jun 5, 2023 | 3 years ago |
| SMA: Bullish | May 29, 2023 | 3 years ago |
| RSI: Oversold | May 22, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 17, 2023 | 3 years ago |
| RSI: Oversold | Apr 3, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 13, 2023 | 3 years ago |
| RSI: Oversold | Mar 6, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Jan 2, 2023 | 3 years ago |
| SMA: Bearish | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Nov 28, 2022 | 3 years ago |
| SMA: Bearish | Nov 14, 2022 | 3 years ago |
| RSI: Oversold | Nov 14, 2022 | 3 years ago |
| SMA: Bullish | Nov 7, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 7, 2022 | 3 years ago |
| RSI: Oversold | Aug 15, 2022 | 4 years ago |
| RSI: Oversold | Aug 1, 2022 | 4 years ago |
| RSI: Oversold | Jun 13, 2022 | 4 years ago |
| RSI: Oversold | May 9, 2022 | 4 years ago |
| MACD: Sell Signal | May 2, 2022 | 4 years ago |
| SMA: Bearish | Mar 28, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 28, 2022 | 4 years ago |
| SMA: Bullish | Feb 21, 2022 | 4 years ago |
| RSI: Oversold | Jan 31, 2022 | 4 years ago |
| SMA: Bearish | Nov 15, 2021 | 4 years ago |
| SMA: Bearish | Nov 8, 2021 | 4 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
| SMA: Bullish | Nov 1, 2021 | 5 years ago |
| SMA: Bearish | Oct 25, 2021 | 5 years ago |
| SMA: Bearish | Oct 25, 2021 | 5 years ago |
| SMA: Bullish | Oct 18, 2021 | 5 years ago |
| SMA: Bullish | Oct 18, 2021 | 5 years ago |
| SMA: Bearish | Oct 11, 2021 | 5 years ago |
| SMA: Bearish | Oct 11, 2021 | 5 years ago |
| SMA: Bullish | Oct 4, 2021 | 5 years ago |
| SMA: Bullish | Oct 4, 2021 | 5 years ago |
| SMA: Bearish | Sep 13, 2021 | 5 years ago |
| SMA: Bullish | Aug 23, 2021 | 5 years ago |
| SMA: Bearish | Aug 9, 2021 | 5 years ago |
| SMA: Bearish | Aug 9, 2021 | 5 years ago |
| MACD: Sell Signal | Aug 9, 2021 | 5 years ago |
| SMA: Bullish | Jul 19, 2021 | 5 years ago |
| SMA: Bearish | Jul 5, 2021 | 5 years ago |
| MACD: Buy Signal | May 3, 2021 | 5 years ago |
| SMA: Bullish | Apr 19, 2021 | 5 years ago |
| SMA: Bullish | Apr 19, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| SMA: Bearish | Mar 22, 2021 | 5 years ago |
| MACD: Sell Signal | Mar 22, 2021 | 5 years ago |
| MACD: Buy Signal | Mar 8, 2021 | 5 years ago |
| SMA: Bullish | Feb 22, 2021 | 5 years ago |
| SMA: Bullish | Feb 8, 2021 | 5 years ago |
| SMA: Bearish | Feb 1, 2021 | 5 years ago |
| SMA: Bearish | Jan 25, 2021 | 5 years ago |
| SMA: Bullish | Dec 21, 2020 | 5 years ago |
| MACD: Sell Signal | Dec 7, 2020 | 5 years ago |
| SMA: Bearish | Nov 30, 2020 | 5 years ago |
| SMA: Bullish | Nov 23, 2020 | 5 years ago |
| SMA: Bearish | Nov 16, 2020 | 5 years ago |
| SMA: Bullish | Aug 3, 2020 | 6 years ago |
| SMA: Bullish | Jul 6, 2020 | 6 years ago |
| SMA: Bearish | Jun 22, 2020 | 6 years ago |
| SMA: Bullish | Jun 15, 2020 | 6 years ago |
| SMA: Bearish | Jun 8, 2020 | 6 years ago |
| MACD: Buy Signal | Jun 8, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| SMA: Bearish | May 4, 2020 | 6 years ago |
| RSI: Oversold | Mar 9, 2020 | 6 years ago |
| MACD: Sell Signal | Mar 2, 2020 | 6 years ago |
| SMA: Bearish | Feb 24, 2020 | 6 years ago |
| SMA: Bearish | Feb 24, 2020 | 6 years ago |
| SMA: Bullish | Jan 13, 2020 | 6 years ago |
| SMA: Bearish | Jan 6, 2020 | 6 years ago |
| SMA: Bullish | Dec 23, 2019 | 6 years ago |
| SMA: Bullish | Nov 25, 2019 | 6 years ago |
| MACD: Buy Signal | Nov 25, 2019 | 6 years ago |
| SMA: Bearish | Nov 11, 2019 | 6 years ago |
| SMA: Bullish | Oct 28, 2019 | 7 years ago |
| SMA: Bearish | Aug 5, 2019 | 7 years ago |
| MACD: Sell Signal | Aug 5, 2019 | 7 years ago |
| SMA: Bearish | Jul 29, 2019 | 7 years ago |
| SMA: Bullish | Jul 22, 2019 | 7 years ago |
| SMA: Bearish | Jul 15, 2019 | 7 years ago |
| SMA: Bullish | Jun 17, 2019 | 7 years ago |
| SMA: Bearish | Jun 10, 2019 | 7 years ago |
| SMA: Bullish | Jun 3, 2019 | 7 years ago |
| SMA: Bullish | Jun 3, 2019 | 7 years ago |
| SMA: Bearish | May 27, 2019 | 7 years ago |
| SMA: Bearish | May 20, 2019 | 7 years ago |
| SMA: Bullish | Apr 22, 2019 | 7 years ago |
| SMA: Bullish | Apr 22, 2019 | 7 years ago |
| SMA: Bearish | Apr 15, 2019 | 7 years ago |
| SMA: Bearish | Apr 15, 2019 | 7 years ago |
| SMA: Bullish | Mar 11, 2019 | 7 years ago |
| SMA: Bearish | Mar 4, 2019 | 7 years ago |
| SMA: Bullish | Feb 25, 2019 | 7 years ago |
| SMA: Bearish | Dec 10, 2018 | 7 years ago |
| SMA: Bullish | Dec 3, 2018 | 7 years ago |
| SMA: Bearish | Nov 26, 2018 | 7 years ago |
Key statistics
- Market cap
- 11.52B
- Enterprise value
- 15.31B
- Trailing P/E
- 0.00
- Forward P/E
- 18.12
- PEG ratio
- 4.04
- Price / sales
- 2.30
- Price / book
- 1.75
- EPS (TTM)
- -0.41
- Beta
- 1.71
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -3.96%
- Revenue (TTM)
- 5.02B
- Revenue growth
- 10.20%
- Free cash flow
- 826.88M
- Total cash
- 530.00M
- Total debt
- 4.23B
- Return on equity
- -2.98%
- Shares outstanding
- 499.62M
- Short % of float
- 9.89%
- 50-day average
- 23.13
- 200-day average
- 23.80
Analyst view
Consensus: buy
- Target (low)
- 24.00
- Target (mean)
- 30.23
- Target (high)
- 34.00
- Strong buy4
- Buy9
- Hold3
- Sell0
- Strong sell0
Next earnings
Nov 6, 2026
Expected Nov 6, 2026. Consensus EPS estimate 0.20328.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2026 | Sep 30, 2026 | 0.2028 | — | — | — |
| Aug 5, 2026 | Jun 30, 2026 | 0.2692 | 0.34 | +0.07 | +26.30% |
| May 6, 2026 | Mar 31, 2026 | 0.3456 | 0.40 | +0.05 | +15.74% |
| Feb 24, 2026 | Dec 31, 2025 | 0.11 | 0.13 | +0.02 | +18.18% |
| Nov 5, 2025 | Sep 30, 2025 | 0.13 | 0.19 | +0.06 | +46.15% |
| Aug 7, 2025 | Jun 30, 2025 | 0.20 | 0.26 | +0.06 | +30.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
| Oct 20, 2026 | Jefferies | down | Buy | Hold |
| Oct 16, 2026 | Goldman Sachs | init | — | Buy |
| Aug 6, 2026 | UBS | main | Buy | Buy |
| Aug 6, 2026 | Keybanc | main | Overweight | Overweight |
| Jul 22, 2026 | Morgan Stanley | main | Equal-Weight | Equal-Weight |
About Elanco Animal Health Incorporated
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- elanco.com
News
- Elanco Animal Health Incorporated (ELAN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $25
- This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
- This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
- Occidental Petroleum To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Tuesday
- This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Jefferies Downgrades Elanco Animal Health to Hold, Lowers Price Target to $24
- This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32
- Elanco Animal Health Reports Q2 2026 Results: Full Earnings Call Transcript
Your note
Sign in to keep a note on ELAN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BETTINGTON TIMOTHY J | Officer | Sale | Oct 14, 2026 | 138,911 |
| CABRAL RAMIRO MARTIN | Officer | Stock Award(Grant) | Feb 26, 2026 | 290,366 |
| DE BRABANDER ELLEN | Officer | Stock Award(Grant) | Mar 31, 2026 | 280,821 |
| HOOVER R DAVID | Director | Stock Award(Grant) | May 20, 2026 | 277,371 |
| KINARD DAVID S | Officer | Stock Award(Grant) | Feb 26, 2026 | 217,697 |
| KURZIUS LAWRENCE ERIK | Director | Purchase | Aug 19, 2026 | 188,647 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Inc. | 13.49% | 67,397,025 | 1.55B | Jun 29, 2026 |
| FMR, LLC | 11.40% | 56,948,819 | 1.31B | Jun 29, 2026 |
| Blackrock Inc. | 9.78% | 48,849,973 | 1.13B | Jun 29, 2026 |
| Primecap Management Company | 9.10% | 45,445,012 | 1.05B | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 5.75% | 28,750,719 | 662.99M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 5.09% | 25,417,271 | 586.12M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 8.63% | 43,107,500 | 994.06M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 17,796,673 | 410.39M | Sep 29, 2026 |
| VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund | 3.55% | 17,751,139 | 409.34M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.18% | 15,872,148 | 366.01M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 11,448,318 | 264.00M | Jun 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 2.07% | 10,339,390 | 238.43M | Aug 30, 2026 |